1. Home
  2. SITM vs VTRS Comparison

SITM vs VTRS Comparison

Compare SITM & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiTime Corporation

SITM

SiTime Corporation

HOLD

Current Price

$681.42

Market Cap

17.3B

Sector

Technology

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$16.24

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SITM
VTRS
Founded
2003
1961
Country
United States
United States
Employees
N/A
30000
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3B
18.7B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
SITM
VTRS
Price
$681.42
$16.24
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$405.00
$13.50
AVG Volume (30 Days)
483.2K
10.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
3.21%
EPS Growth
57.53
N/A
EPS
0.47
0.05
Revenue
$326,660,000.00
$14,299,900,000.00
Revenue This Year
$49.65
$4.41
Revenue Next Year
$27.77
$1.96
P/E Ratio
$1,587.74
$324.60
Revenue Growth
61.16
N/A
52 Week Low
$204.81
$9.43
52 Week High
$901.81
$18.39

Technical Indicators

Market Signals
Indicator
SITM
VTRS
Relative Strength Index (RSI) 54.34 44.30
Support Level $657.38 $15.82
Resistance Level $763.31 $16.54
Average True Range (ATR) 42.97 0.51
MACD 15.68 -0.14
Stochastic Oscillator 68.22 20.12

Price Performance

Historical Comparison
SITM
VTRS

About SITM SiTime Corporation

SiTime Corp is a provider of Precision Timing solutions to the international electronics industry, providing the timing functionality needed for electronics to operate reliably and correctly. The Company's products are designed to address a wide range of applications across a broad array of end markets. The Company operates a fabless business model and leverages its international network of distributors to address the end markets it serves. The Company operates in one reportable segment related to the design, development, and sale of silicon timing systems solutions. It operates in Hong Kong, Taiwan, the United States, Singapore, and other regions, with the majority of revenue coming from Hong Kong.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: